Skip to main content

Table 2 Univariate and multivariate analysis results (n = 103)

From: Validation of bidimensional measurement in nasopharyngeal carcinoma

 

Overall survival

Metastasis

Any recurrence

 

Univariate

HR (95% CI)

Multivariate*

HR (95% CI)

Univariate

HR (95% CI)

Multivariate*

HR (95% CI)

Univariate

HR (95% CI)

Multivariate*

HR (95% CI)

GTVprn

1.07 (1.037-1.103)

1.069 (1.033-1.107)

1.049 (1.013-1.085)

1.05 (1.01-1.091)

1.048 (1.018-1.079)

1.037 (1.004-1.071)

 

P < 0.001

P < 0.001

P = 0.007

P = 0.013

P = 0.002

P = 0.028

BDMprn

1.071 (1.021-1.122)

1.012 (1.014-1.12)

1.06(1.006-1.116)

1.06 (1.002-1.121)

1.046 (1.002-1.093)

1.038 (0.99-1.088)

 

P = 0.004

P = 0.012

P = 0.028

P = 0.042

P = 0.041

P = 0.121

BDMp

1.056 (1.001-1.113)

1.048 (0.991-1.108)

1.041 (0.983-1.116)

1.043 (0.981-1.108)

1.043 (0.993-1.096)

1.037 (0.984-1.092)

 

P = 0.045

P = 0.099

P = 0.169

P = 0.176

P = 0.091

P = 0.173

  1. GTVprn, gross tumor volume of primary tumor and retropharyngeal nodes; BDMprn, bidimensional measurement of primary tumor and retropharyngeal nodes; BDMp, bidimensional measurement of primary tumor; HR, hazard ratio; 95% CI, 95% confidence interval.
  2. *Multivariate analysis: adjusted for age, gender, and chemotherapy status.